← Back to headlines
Wolfe Research Upgrades Moderna Stock on Pipeline Optimism
Investment firm Wolfe Research has upgraded its rating on Moderna shares, citing strong prospects for the company's mRNA technology platform and upcoming clinical developments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
